Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals, Inc.
“This relationship represents a strategic collaboration to identify novel drugs in the area of infectious diseases from the exploitation of the unique natural products resources from Fundación MEDINA“ said Dr Olga Genilloud, Fundación MEDINA Scientific Director. “MEDINA provides the expertise and tools for maximising the probability of success in the collaboration with Cubist and the discovery of promising compounds for the treatment of serious multidrug resistant infections”.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.